Relationship between prostate cancer and atypical small acinar proliferation
Main Article Content
Abstract
Aim: To investigate the prostatic adenocarcinoma (PA) detection rate in follow up biopsies with an initial diagnosis of atypical small acinar proliferation (ASAP).
Materials and Methods: In this study, the cases of ASAP diagnosis in prostate needle biopsy materials between January 2010 and December 2016 were retrospectively analyzed and the correlation between the results and the follow-up diagnoses of ASAP-diagnosed cases was investigated.
Results: 62 cases with ASAP were included in the study and 21 (34%) of them were detected as PA after the follow-up diagnoses. Also ASAP and PA were detected at different localizations in 38% of the cases.
Conclusion: We are on the opinion that it is important to increase the number of samples taken from other localizations as well as ASAP diagnosed quadrants when taking follow-up biopsies.
Materials and Methods: In this study, the cases of ASAP diagnosis in prostate needle biopsy materials between January 2010 and December 2016 were retrospectively analyzed and the correlation between the results and the follow-up diagnoses of ASAP-diagnosed cases was investigated.
Results: 62 cases with ASAP were included in the study and 21 (34%) of them were detected as PA after the follow-up diagnoses. Also ASAP and PA were detected at different localizations in 38% of the cases.
Conclusion: We are on the opinion that it is important to increase the number of samples taken from other localizations as well as ASAP diagnosed quadrants when taking follow-up biopsies.
Downloads
Download data is not yet available.
Article Details
How to Cite
Ceylan, O., Demirtas, R., Kurt, A., Can, Y., Esref Kabalar, M., Erkan Bilici, A., & Balta, H. (2021). Relationship between prostate cancer and atypical small acinar proliferation . Annals of Medical Research, 26(5), 0850–0853. Retrieved from https://annalsmedres.org/index.php/aomr/article/view/3675
Section
Original Articles
CC Attribution-NonCommercial-NoDerivatives 4.0